Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib
Published date:
10/28/2011
Excerpt:
Lapatinib-resistant ERBB2 mutations were found to be highly resistant towards AEE788 treatment but remained sensitive towards the dual irreversible inhibitors CL-387785 and WZ-4002.